Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
#:"(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)"
(allfields_unstemmed:2019-nCov OR allfields:2019nCov OR allfields_unstemmed:2019nCov OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 OR allfields_unstemmed:Sars-CoV-2 OR allfields_unstemmed:COVID-19 NOT format:Book NOT collection_details:ZDB-2-SEB)
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Liao%2C+Ran%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
/vufind/Search/Results?lookfor=%22Liao%2C+Ran%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
Search /vufind/Search2/Results?lookfor=%22Liao%2C+Ran%22&type=Person&filter%5B%5D=%28allfields_unstemmed%3A2019-nCov+OR+allfields%3A2019nCov+OR+allfields_unstemmed%3A2019nCov+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19+OR+allfields_unstemmed%3ASars-CoV-2+OR+allfields_unstemmed%3ACOVID-19++NOT+format%3ABook+NOT+collection_details%3AZDB-2-SEB%29
PubPharm (9)
1
Efficacy and safety of baricitinib in patients with COVID-19 infection: Results from the randomised, double-blind, placebo-controlled, parallel-group COV-BARRIER phase 3 trial
enthalten in:
bioRxiv.org
| 2023
von
Marconi, V.
|
Ramanan, A.
|
de Bono, S.
| +16
Wird geladen...
2
Platform trials to evaluate the benefit-risk of COVID-19 therapeutics : Successes, learnings, and recommendations for future pandemics
enthalten in:
Contemporary clinical trials
| 2023
von
Buenconsejo, J.
|
Liao, R.
|
Lin, J.
| +6
Wird geladen...
3
Estimands, Handling of Missing Data and Impact on Assumed Effect Size and Power in Pivotal COVID-19 Treatment Trials
enthalten in:
Journal of biopharmaceutical statistics
| 2023
von
Chakladar, S.
|
Liao, R.
|
Gamalo, M.
Wird geladen...
4
Win ratio approach for analyzing composite time-to-event endpoint with opposite treatment effects in its components
enthalten in:
Pharmaceutical statistics
| 2022
von
Liao, R.
|
Chakladar, S.
|
Gamalo, M.
Wird geladen...
5
Uncovering the disposable face masks as vectors of metal ions (Pb(Ⅱ), Cd(Ⅱ), Sr(Ⅱ)) during the COVID-19 pandemic
enthalten in:
Chemical engineering journal (Lausanne, Switzerland : 1996)
| 2022
von
Lin, L.
|
Yuan, B.
|
Zhang, B.
| +6
Wird geladen...
6
Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or extracorporeal membrane oxygenation : an exploratory, randomised, placebo-controlled trial
enthalten in:
The Lancet. Respiratory medicine
| 2022
von
Ely, E.
|
Ramanan, A.
|
Kartman, C.
| +25
CommentIn: Lancet Respir Med. 2022 Apr;10(4):314-315. - PMID 35123659
Wird geladen...
7
Win ratio approach for analyzing composite time‐to‐event endpoint with opposite treatment effects in its components
enthalten in:
Pharmaceutical Statistics
| 2022
von
Liao, R.
|
Chakladar, S.
|
Gamalo, M.
Wird geladen...
8
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER) : a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial
enthalten in:
The Lancet. Respiratory medicine
| 2021
von
Marconi, V.
|
Ramanan, A.
|
de Bono, S.
| +105
CommentIn: Lancet Respir Med. 2021 Dec;9(12):1349-1351. - PMID 34480862
Wird geladen...
9
Baricitinib plus Standard of Care for Hospitalised Adults with COVID-19 on Invasive Mechanical Ventilation or Extracorporeal Membrane Oxygenation: Results of a Randomised, Placebo-Controlled Trial
enthalten in:
bioRxiv.org
| 2021
von
Ely, E.
|
Ramanan, A.
|
Kartman, C.
| +7
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Filter aufheben
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
9
Aufsätze
9
E-Artikel
9
E-Ressourcen
Zeitschriftentitel
2
The Lancet. Respiratory medicine
2
bioRxiv.org
1
Chemical engineering journal (Lausanne, Switzer...
1
Contemporary clinical trials
1
Journal of biopharmaceutical statistics
1
Pharmaceutical Statistics
1
Pharmaceutical statistics
Alle anzeigen ...
weniger ...
Thema
6
Journal Article
2
Azetidines
2
COVID-19
2
Clinical Trial, Phase III
2
ISP4442I3Y
2
Purines
2
Pyrazoles
2
Randomized Controlled Trial
2
Sulfonamides
2
baricitinib
1
3QKI37EEHE
1
415SHH325A
1
570
1
7S5I7G3JQL
1
Adenosine Monophosphate
1
Adrenal Cortex Hormones
1
Adsorption mechanisms
1
Alanine
1
Antiviral Agents
1
Biology
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
3
2023
4
2022
2
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
8
Englisch
Haven't found what you're looking for?
Wird geladen...